TREA

98044695 - TESCENDO

Follow

Information

  • Trademark
  • 98044695
  • Serial Number
    98044695
  • Filing Date
    June 15, 2023
    a year ago
  • Transaction Date
    October 16, 2024
    16 days ago
  • Status Date
    September 30, 2024
    a month ago
  • Published for Opposition Date
    November 05, 2024
    3 days from now
  • Location Date
    September 30, 2024
    a month ago
  • Status Code
    681
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    GILLES, DEBORAH
  • Attorney Name
    A. Reagan Fibbe
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
TESCENDO
Case File Statements
  • GS0401: Custom manufacturing of pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing; manufacturing of cell therapy platforms for others
  • GS0051: Cells for medical or clinical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; therapeutic kits comprised of biological and pharmaceutical preparations for use in treatment and therapy for cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; test kits for diagnostic preparations for medical purposes comprised of medical diagnostic reagents and assays for testing of body fluids and also containing a sample preparation device for medical diagnostic uses; T-cell receptors expressed on the cell for use in connection with diagnosing and treating cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; diagnostic reagents for medical clinical use for treatment of cancer; cell culture kits for medical use primarily comprised of imaging and detection agents for diagnosing and monitoring cancer, and also containing a diagnostic apparatus for medical purposes used in medical laboratories for testing cancer cells; medical testing and treatment product kits primarily comprised of cells for diagnosing and treating cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders
  • GS0011: Reagents for scientific and research purposes, drug discovery research and scientific development, and biological and pharmaceutical reagents, for scientific and research purposes, for use in the manufacturing process of cell therapy platforms; diagnostic reagents for scientific clinical use for treatment of cancer
  • GS0441: Medical services; medical services, namely, cellular immunotherapy treatments; medical services, namely, human cancer treatment; providing medical information relating to immunotherapy; providing cancer therapy advice and consultancy
  • GS0421: Medical and scientific research services; medical laboratory services; providing information on medical and scientific research in the field of oncology; compiling and analyzing data for research purposes in the field of oncology; consulting in the field of medical and scientific research
Case File Event Statements
  • 6/19/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/19/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/3/2024 - 6 months ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 8/7/2024 - 2 months ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/7/2024 - 2 months ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/7/2024 - 2 months ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/31/2024 - 9 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/7/2024 - 8 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/7/2024 - 8 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/7/2024 - 8 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/3/2024 - 6 months ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 9/15/2024 - a month ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/15/2024 - a month ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/15/2024 - a month ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 9/24/2024 - a month ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/16/2024 - 16 days ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/15/2024 - a month ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA